Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 15, 2010

Drug Name	Review Type	Class	Manufacturer
Zirgan	New Drug Initial Review	Antiviral	Bausch & Lomb
Oravig	New Drug Initial Review	Antifungal	Strativa
Cetraxal	New Drug Initial Review	Otic Antibiotic	Wraser
Lysteda	New Drug Initial Review	Antifibrinolytic	Ferring
Oleptro	New Drug Initial Review	Antidepressant	Labopharm
Pancreaze	New Drug Initial Review	Pancreatic Enzyme	OMJPI
Xifaxan 550	New Drug Appeal	Antibiotic	Salix
Bepreve	New Drug Appeal	Ophthalmic- Allergic Conjunctivitis	Ista
Colcrys	New Drug Appeal	Anti-Gout	URL
Fanapt	New Drug Appeal	Atypical Antipsychotic	Novartis
Pristiq	New Drug Appeal	SNRI Antidepressant	Pfizer
Saphris	PDL Appeal	Atypical Antipsychotic	Merck
Vesicare	PDL Appeal	Urinary Anti-Incontinence	Astellas